Review
Treatment of macular edema after vitrectomy
Beibei Wang, Qiuming Li, Shuqian Dong, Zhirou Hu
Published 2019-12-22
Cite as Int Rev Ophthalmol, 2019, 43(6): 366-372. DOI: 10.3760/cma.j.issn.1673-5803.2019.06.002
Abstract
The occurrence of macular edema (ME) after pars plana vitrectomy (PPV) severely affects postoperative visual acuity. Corticosteroids can effectively control the inflammatory response. It is currently the main method for the treatment of inflammation-related ME after PPV. It can be applied topically, peri-injection, or intravitreal injection of long-acting or short-acting glucocorticoids. Other treatments include surgical removal of macular membrane-like traction, vitreous injection of anti-vascular endothelial growth factor(VEGF), topical application of non-steroidal anti-inflammatory drugs, oral carbonic anhydrase inhibitors, subcutaneous injection of alpha-2a interferon and topical betalol.(Int Rev Ophthalmol, 2019, 43: 366-372)
Key words:
macular edema; vitrectomy; vascular endothelial growth factor; glucocorticoid
Contributor Information
Beibei Wang
Department of Ophthalmology, the First Affiliated Hospital of Zhengzhou University, Henan Provincial Ophthalmic Hospital, Zhengzhou 450052, China
Qiuming Li
Department of Ophthalmology, the First Affiliated Hospital of Zhengzhou University, Henan Provincial Ophthalmic Hospital, Zhengzhou 450052, China
Shuqian Dong
Department of Ophthalmology, the First Affiliated Hospital of Zhengzhou University, Henan Provincial Ophthalmic Hospital, Zhengzhou 450052, China
Zhirou Hu
Department of Ophthalmology, the First Affiliated Hospital of Zhengzhou University, Henan Provincial Ophthalmic Hospital, Zhengzhou 450052, China
